Singapur -
inglise -
HSA (Health Sciences Authority)
soliqua solution for injection in a pre-filled pen 100unitsml + 50mcgml
sanofi-aventis singapore pte. ltd. - insulin glargine; lixisenatide - injection, solution - insulin glargine 100 units/ml; lixisenatide 50 μg/ml
Malaisia -
inglise -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
soliqua solostar 100unitsml+33mcgml solution for injection in a pre-filled pen
sanofi-aventis (malaysia) sdn. bhd. - insulin glargine; lixisenatide -
Malaisia -
inglise -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
soliqua solostar 100unitsml+50mcgml solution for injection in a pre-filled pen
sanofi-aventis (malaysia) sdn. bhd. - insulin glargine; lixisenatide -
Iisrael -
inglise -
Ministry of Health
suliqua 10033
sanofi israel ltd - insulin glargine; lixisenatide - solution for injection - lixisenatide 33 mcg / 1 ml; insulin glargine 100 units / 1 ml - insulin glargine - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sodium-glucose co-transporter-2 (sglt-2) inhibitors
Iisrael -
inglise -
Ministry of Health
suliqua 10050
sanofi israel ltd - insulin glargine; lixisenatide - solution for injection - lixisenatide 50 mcg / 1 ml; insulin glargine 100 units / 1 ml - insulin glargine - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sodium-glucose co-transporter-2 (sglt-2) inhibitors.
Iisrael -
inglise -
Ministry of Health
ozempic
novo nordisk ltd., israel - semaglutide - solution for injection - semaglutide 1.34 mg / 1 ml - semaglutide - ozempic is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in addition to other medicinal products for the treatment of diabetes.
Suurbritannia -
inglise -
MHRA (Medicines & Healthcare Products Regulatory Agency)
liraglutide 6mg/ml solution for injection 3ml pre-filled disposable devices
colorama pharmaceuticals ltd - liraglutide - solution for injection - 6mg/1ml
Suurbritannia -
inglise -
MHRA (Medicines & Healthcare Products Regulatory Agency)
liraglutide 6mg/ml solution for injection 3ml pre-filled disposable devices
j m mcgill ltd - liraglutide - solution for injection - 6mg/1ml
Suurbritannia -
inglise -
MHRA (Medicines & Healthcare Products Regulatory Agency)
liraglutide 6mg/ml solution for injection 3ml pre-filled disposable devices
niche pharma ltd - liraglutide - solution for injection - 6mg/1ml
Suurbritannia -
inglise -
MHRA (Medicines & Healthcare Products Regulatory Agency)
liraglutide 6mg/ml solution for injection 3ml pre-filled disposable devices
de pharmaceuticals - liraglutide - solution for injection - 6mg/1ml